Ascendis Pharma A/S (ASND) stock
Close on Nov 12, 2026Market cap $16.55BP/E 21.7Yield –
Ascendis Pharma A/S statistics
74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Valuation ratiosIndustry
- P/OCF Ratio
- 42.46
- –
Enterprise valuationIndustry
- EV / Sales
- 13.76
- 4.00
- EV / EBIT
- 54.15
- –
Share statisticsIndustry
- Shares Change (YoY)
- 5.61%
- 5.61%
- Float
- 61M
- 79M
- Shares Held by Insiders
- 0.83%
- 9.05%
- Shares Held by Institutions
- 108.0%
- 20.8%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -4.30%
- -2.55%
- Days to Cover
- 4.99
- 3.54
Stock price statisticsIndustry
- Price Change (1 Week)
- 5.37%
- 3.30%
- Price Change (1 Month)
- 17.7%
- 4.20%
- Price Change (3 Months)
- 7.47%
- -15.8%
- Price Change (6 Months)
- 8.79%
- -17.6%
- Price Change (YTD)
- 25.2%
- -12.8%
- Price Change (1 Year)
- 32.8%
- -19.5%
- Price Change (3 Years)
- 198.6%
- -3.74%
- Price Change (5 Years)
- 71.5%
- -54.2%
- Price Change (10 Years)
- 1270.3%
- -41.5%
- Average Volume (10 Days)
- 747,290
- –
- Average Volume (20 Days)
- 694,460
- –
- Average Volume (90 Days)
- 671,722
- –
- Relative Volume
- 1.92
- 0.96
- Relative Strength Index (14)
- 70.2
- 51.0
- Volatility (1 Year)
- 38.5%
- 65.1%
- Beta (5 Years)
- 0.75
- 0.86
MarginsIndustry
- Pretax Margin
- 9.34%
- -36.6%
- EBITDA Margin
- 25.4%
- -28.6%
Returns on capitalIndustry
- Return on Assets (ROA)
- 44.0%
- -1.57%
- Return on Capital Employed (ROCE)
- 14.6%
- -23.8%
Financial positionIndustry
- Current Ratio
- 2.99
- 3.49
- Quick Ratio
- 2.19
- 1.51
- Debt / EBITDA
- 1.45
- –
- Net Debt / EBITDA
- -1.61
- –
- Interest Coverage
- 1.27
- -0.71
GrowthIndustry
- Revenue Growth (YoY)
- 113.4%
- -1.08%
- Revenue Growth (3Y CAGR)
- 141.4%
- 1.61%
- Revenue Growth (5Y CAGR)
- 153.0%
- 14.0%
EfficiencyIndustry
- Asset Turnover
- 0.62
- 0.31
- Inventory Turnover
- 0.30
- 1.36
- Revenue Per Employee
- €1.19M
- €855.98K
- Profits Per Employee
- €843.87K
- -€43.26K
- Employee Count
- 879
- 304
- WACC
- 8.91%
- 9.42%
Income statement (TTM)Industry
- Pretax Income
- €97.84M
- -€47.40M
Balance sheetIndustry
- Net Cash (Debt)
- €427.62M
- €111.50M
- Net Cash Per Share
- 6.90 EUR
- 1.53 EUR
- Working Capital
- €925.52M
- €119.55M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 5.00%
- -1.71%
- Buyback Yield
- 0.70%
- -11.1%
- Shareholder Yield
- 0.70%
- -11.1%
Taxes and interestIndustry
- Interest Expense
- €210.31M
- €55.20M
- Income Tax
- -€643.92M
- €80.00K
- Effective Tax Rate
- -658.1%
- –
Scores and fair valueIndustry
- Altman Z-Score
- 11.81
- 1.23
- Piotroski F-Score
- 5
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ASND | S&P 500 | Difference | ASND per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +17.7% | -2.7% | +20.3 pts | ||
| 3 months | +4.5% | -1.7% | +6.3 pts | ||
| Year to date | +25.2% | +11.9% | +13.3 pts | ||
| 1 year | +34.1% | +12.0% | +22.1 pts | ||
| 3 years | +195.8% | +78.2% | +117.6 pts | +43.6% | +21.2% |
| 5 years | +71.5% | +73.2% | −1.7 pts | +11.4% | +11.6% |
| 10 years | +1270.3% | +309.6% | +960.6 pts | +29.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M ASND shares were sold short on Oct 30, 2026, down 4.3% from the previous report. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 55.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,997,710 | -4.3% | 600,847 | 5.0 |
| Oct 15, 2026 | 3,132,475 | -10.1% | 755,159 | 4.2 |
| Sep 30, 2026 | 3,484,067 | -12.1% | 937,174 | 3.7 |
| Sep 15, 2026 | 3,961,960 | -5.7% | 808,088 | 4.9 |
| Aug 31, 2026 | 4,203,221 | +14.0% | 442,630 | 9.5 |
| Aug 14, 2026 | 3,687,311 | +8.3% | 589,552 | 6.3 |
| Jul 31, 2026 | 3,404,687 | +9.7% | 472,453 | 7.2 |
| Jul 15, 2026 | 3,104,151 | -5.3% | 552,854 | 5.6 |
| Jun 30, 2026 | 3,277,898 | +65.0% | 1,302,350 | 2.5 |
| Jun 15, 2026 | 1,987,044 | +15.5% | 576,428 | 3.5 |
| May 29, 2026 | 1,720,143 | -0.1% | 555,522 | 3.1 |
| May 15, 2026 | 1,721,179 | -39.2% | 623,378 | 2.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?